WOONSOCKET, R.I., May 9, 2024 /PRNewswire/ -- A recent CVS Health® (NYSE: CVS)/Morning Consult survey found that a majority of adults have significant concerns about their mental health and rates across the country continue to rise.
"Mental health became a top concern in 2020 and it has only risen since," said Taft Parsons III, M.D., Vice President and Chief Psychiatric Officer, CVS Health. "Uncertainty around the future, current events and social media continue to drive anxiety among adults. Our priority, across CVS Health, remains improving access to quality virtual and in-person mental health care and ensuring we have resources in place to address the unique needs of individuals."
Americans are concerned about social media's implications on their mental health
The survey also found that nearly four in 10 adults (37%) believe social media has hurt society at-large.
"Our increasing use of technology has helped increase access to mental health care – CVS Health has had over 43 million mental health virtual visits since 2020 – and created a way for people to talk openly about the topic, reducing stigma," added Parsons III. "But as we navigate the impacts social media has on mental health, it has become increasingly important that we highlight its limitations and set guardrails for ourselves and our children."
CVS Health's commitment to mental health care
As the leading health solutions company with resources that expand nationally and in communities across the country, CVS Health continues to increase accessibility to both in-person and virtual mental health services:
For more information on how CVS Health is making mental well-being services more accessible, less complicated and more convenient, visit CVSHealth.com.
Methodology
This poll was conducted by Morning Consult between March 19-21, 2024, among a national sample of 2,202 adults. The margin of error for the full sample is plus or minus two percentage points. The interviews were conducted online and the data were weighted to approximate a target sample of adults based on age, gender, educational attainment, race, and region.
CVS Health® is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues – including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health – whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system – and their personal health care – by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
Media Contacts
Ethan Slavin
This email address is being protected from spambots. You need JavaScript enabled to view it.
Doug Feingold
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$56.83 |
Daily Change: | 1.06 1.90 |
Daily Volume: | 11,060,119 |
Market Cap: | US$71.610B |
November 19, 2024 November 18, 2024 November 06, 2024 November 06, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREChimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB